RxDoctor Payments Data

Sean Stoy, MD

Pulmonary Disease · Robbinsdale, MNNPI 1255504080

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (46.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 73.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $13,450 and has fallen 94.9% since, to $692 in 2024. Among pulmonary disease clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,389in general payments, 2019–2025

Across 75 payments — averaging $258.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$14K
  • Body Vision Medical Inc.$3K
  • Johnson & Johnson$639
  • Pulmonx Corporation$613
  • Pinnacle Biologics, Inc$413
  • Covidien LP$214
  • plus $780 from 9 others

What the payments were for

  • Consulting fees$2,20011%
  • Speaking & faculty fees$2001%
  • Travel & lodging$3,70019%
  • Food & beverage$4,27322%
  • Education$9,01647%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical36$14,214
Body Vision Medical Inc.6$2,516
Johnson & Johnson7$639
Pulmonx Corporation9$613
Pinnacle Biologics, Inc3$413
Covidien LP3$214
Boston Scientific1$169
Serpex Medical Inc1$131
Noah Medical Corporation1$120
Olympus America Inc.2$110
Galvanize Therapeutics, Inc1$91
Imbio Inc.1$85
Medtronic2$37
Philips North America LLC1$21
Insmed, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,389 in reported general payments places this provider in the 95th percentile of 261 pulmonary disease providers in Minnesota.

See all pulmonary disease providers in Minnesota

Medicare billing

Part B allowed, 2024
$33,966
Medicare patients
110
Services billed
322

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XolairOmalizumab13$21,235
Breo ElliptaFluticasone/Vilanterol12$4,703
Azithromycin16$409
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$147
Prednisone17$62

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Robbinsdale

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →